drug
as of 2026-07-013-(2,4 dimethoxybenzylidene anabaseine) 75 mg
at a glance
small molecule
Pre-approval / investigational in the US
Developed by University of Colorado, Denver
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
NCT00100165Phase 2Completed
KOLs & investigators
1
Robert Freedman, MDKOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here